Request to Join
has invited you to join this group
Education and current employment: MD 1987 (University of Copenhagen), specialized in internalmedicine, infectious diseases and tropicalmedicine; professorininfectious disease epidemiology and in viral diseases 2005 and 2007, resp. (University ofCopenhagen). Since 1998 Director of CHIP, Centre for Health and Infectious Disease Research. Since 2015, center leader of National Research Foundation Center of Excellence PERSIMUNE. Research achievements: Has 20+ years of expertise in leading large internationalresearch related to infectious complications in HIV+ persons and transplant recipients funded by the European Commission (EuroSIDA in EuroCoord), the European Medicines Agency (D:A:D) and NIH (INSIGHT studies). Lead of the European‐funded networks and co‐founder of the global infectious disease research network INSIGHT. Founded MATCH in 2010 to monitor viral infections in transplant patients at Rigshospitalet, now by a grant from the Danish National Research Foundation turned into a research platform across Rigshospitalet to identify factors predicting the risk of infectious complication in immune deficient patients. Coordinating activities among 250+ international institutions documents his ability to manage large data mergers and perform hypotheses‐driven and ‐generating research. Recent years he focused on establishing evidence for the optimal initiation of antiretroviral therapy in HIV infected patients, investigating non‐AIDS defining malignancies and inflammation mediated organ disease, especially focused on kidney, liver and cardiovascular diseases; viral diseases in transplant recipients and the impact of changing mutations of influenza viruses in the global epidemic. His team is Global Centre of Excellence in Health and has status of ‘Collaborative Centre for HIV and Viral Hepatitis’ by the WHO. Supervised 19 PhDs and 6DMScs and has ongoing supervision for 12PhDs and 4DMScs.
Rebecca M. Zash, MD is an Instructor in Medicine, Division of Infectious Diseases and Associate Director for Global Health Programs, Internal Medicine Residency, Beth Israel Deaconess Medical Center, Boston, MA. Dr. Zash's research focuses on monitoring of drug safety in pregnancy in resource-limited settings. She currently works in Botswana with the Botswana-Harvard AIDS Institute Partnership on one of the largest birth outcomes surveillance studies in Africa, aiming to understand effect of antiretroviral therapy in pregnancy on maternal and infant outcomes. In addition to clinical work as an Infectious Diseases physician, Dr. Zash serves as the associate director for the Beth Israel Deaconess Medical Center (BIDMC) Global Health Program and Global Health Fellowship in Medicine.
Assistant in Gynecology and Obstetrics, at University Paris Descartes, Paris, France.
Epidemiologist for the French Perinatal Cohort, INSERM CESP 1018, Le Kremlin-Bicêtre, France.
Dr. Serghides is a Scientist at the Toronto General Research Institute at the University Health Network and an Assistant Professor at the Department of Immunology and the Institute of Medical Sciences at the University of Toronto. Her current research focus is on understanding the mechanisms that contribute to the increased risk for adverse pregnancy outcomes in women with HIV, and on the long-term effects of in utero exposure to HIV antiretrovirals. The research is motivated by the goal of optimizing maternal and infant health in the context of infections of global health importance.
Mark Mirochnick, MD is Professor of Pediatrics and Chief of the Division of Neonatology at Boston Medical Center/Boston University School of Medicine. He is a leading investigator of the pharmacology of antiretrovirals in pregnant women, neonates and infants. He is co-chair of the DHHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission and is a member of the DHHS Panel on Antiretroviral Therapy and Medical Management of HIV-infected Children and of the WHO Pediatric Antiretroviral Working Group.